Using ctDNA to Determine Therapies for Lung Cancer
Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
This is a study to look at whether the presence of circulating tumour DNA (ctDNA) in the
blood can help to predict whether giving adjuvant treatment after surgery can decrease the
chance of the cancer coming back in people with lung cancer.